re: usa ecg sales up 100% here's report ASX RELEASEMedical...

re: usa ecg sales up 100% here's report ASX RELEASE
Medical Monitors Limited
Suite 407 Westfield Eastgardens
Eastgardens NSW 2036
Tel (02) 9344 8100 Fax (02) 9344 8200
Web site: www.medmon.com.au
4 April 2005
USA ECG Sales Update
The Directors of Medical Monitors Limited (ASX: MDM) are pleased to advise that
Primedical International, Plc, (Primedical), the exclusive holder of license and distribution
rights for Medical Monitors products and service for the USA, has increased its purchase
order for ECG monitoring units (the suPER) by 100%.
The initial order of 5,000 units (contracted at USD$35 per unit) has now been increased
to 10,000 units, which are to be supplied as soon as is possible. Primedical has
confirmed that its USA monitoring business is ahead of budget and that it has secured
contracts to supply ECG units to a number of major medical clinics. Medical Monitors will
have direct benefit from the manufacturing and royalty revenue.
Medical Monitors’ technology and service model remain superior to the current market
offerings in transtelephonic (telephone transfer) cardiac monitoring, and the company is
well placed to take a substantial share of the lucrative US arrhythmia monitoring market
estimated to be USD$550 million per annum. This technology, which allow doctors to
remotely monitor the cardiovascular health of their patients, has already been granted
United States Food and Drug Administration (FDA) notification to enable marketing and
sales.
For further information, please contact Dr Allan Shell on (02) 9344 8100.